Locally Advanced Prostate Cancer Clinical Trials

5 recruiting

Locally Advanced Prostate Cancer Trials at a Glance

6 actively recruiting trials for locally advanced prostate cancer are listed on ClinicalTrialsFinder across 6 cities in 3 countries. The largest study group is Not Applicable with 2 trials, with the heaviest enrollment activity in Aarhus, Cleveland, and Copenhagen. Lead sponsors running locally advanced prostate cancer studies include Angela Y. Jia, MD PhD, First Affiliated Hospital of Fujian Medical University, and Jiangsu HengRui Medicine Co., Ltd..

Browse locally advanced prostate cancer trials by phase

Treatments under study

About Locally Advanced Prostate Cancer Clinical Trials

Looking for clinical trials for Locally Advanced Prostate Cancer? There are currently 5 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Locally Advanced Prostate Cancer trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Locally Advanced Prostate Cancer clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 16 of 6 trials

Recruiting
Phase 1

Relugolix + Enzalutamide Study in High-Risk Prostate Cancer

Androgen Deprivation TherapyLocally Advanced Prostate Cancer
University of Oklahoma46 enrolled1 locationNCT06130995
Recruiting
Not Applicable

Addition of Focal Boost to Primary Radiotherapy for Prostate Cancer in 12 or 20 Fractions

Locally Advanced Prostate CancerProstate Cancer Patients Undergoing External Radiation and Seed ImplantationHigh Risk Localised Prostate Carcinoma+1 more
Rigshospitalet, Denmark1,016 enrolled3 locationsNCT07343349
Recruiting
Phase 1Phase 2

STereotActic Body Radiotherapy and 177Lutetium PSMA in Locally Advanced Prostate Cancer

Malignant Neoplasm of ProstateLocally Advanced Prostate Cancer
Angela Y. Jia, MD PhD45 enrolled1 locationNCT06574880
Recruiting
Not Applicable

Improved Robotic-Assisted Radical Prostatectomy for Locally Advanced Prostate Cancer: Bladder Suspension and Preliminary Outcomes

Locally Advanced Prostate CancerRobotic-Assisted Radical ProstatectomyBladder Suspension
First Affiliated Hospital of Fujian Medical University300 enrolled1 locationNCT06977906
Recruiting
Phase 2

Genomic Biomarker-guided Neoadjuvant Therapy for Prostate Cancer (SEGNO)

Locally Advanced Prostate CancerOligometastatic Prostate Cancer
The First Affiliated Hospital of Xiamen University40 enrolled1 locationNCT06387056
Recruiting
Phase 3

A Trial of SHR3680 in Prostate Cancer Patients Who Are Candidates for Radical Prostatectomy

Patients With High-risk Localized or Locally Advanced Prostate Cancer Who Are Candidates for Radical Prostatectomy
Jiangsu HengRui Medicine Co., Ltd.1,256 enrolled1 locationNCT05009290